As of September 17, 2026, Syngene's stock is trading at ₹380.2, indicating a bearish trend on the daily timeframe. The daily chart shows the price below key moving averages including the 20-day EMA (₹392.07) and 50-day SMA (₹403.07), with a bearish Supertrend signal at ₹403.6. This is supported by a declining ADX value of 21.47, suggesting weakening trend strength, and negative DI readings relative to positive DI (25.28 vs 11.33). The weekly timeframe also shows a bearish Supertrend at ₹454.22, with the price below the 20-day EMA (₹417.89) and 50-day SMA (₹483.89). In contrast, the monthly timeframe exhibits a bullish Supertrend at ₹375.57, with the price above this level, although the 20-day EMA (₹525.47) and 20-day SMA (₹550.59) are significantly higher, indicating a strong monthly uptrend that is currently being challenged on shorter timeframes. Recent daily patterns include an active "Doji" and "Inside Bar" on September 17, 2026, suggesting potential indecision. The stock is currently trading near its nearest support level of ₹378.9, which is approximately 0.34% below the current price. The nearest resistance is at ₹383.6, about 0.89% higher. The stock has experienced a drawdown of -0.57% and has an annualized volatility of 0.31. Key watch conditions include monitoring the price action around the ₹378.9 support and ₹383.6 resistance levels. A break below ₹378.9 could signal further downside, while a sustained move above ₹383.6 may indicate a short-term recovery. The divergence between the daily/weekly bearish signals and the monthly bullish Supertrend warrants close observation for potential trend alignment or continuation of the short-term weakness within a larger monthly uptrend.

Syngene International Limited has announced its participation in an upcoming investor meet organized by Kotak Group. The company is scheduled for a physical one-on-one meeting with Healthcare Forum 2026 in Mumbai on September 17, 2026. Syngene has explicitly stated that no Unpublished Price Sensitive Information (UPSI) will be disclosed during this event. This follows a series of filings on September 11 and September 12, 2026, confirming the schedule for this and other analyst or institutional investor meetings. Earlier in the month, on September 1, 2026, Syngene informed the exchange about the grant of 14,26,061 Performance Share Units (PSUs) under its Long Term Incentive Performance Share Plan (PSP) 2023 to eligible employees. These PSUs have an exercise price of ₹10 per unit and are subject to a three-year vesting period, with options exercisable within five years from vesting.

Syngene International, trading on the NSE, has experienced a minor price fluctuation. As of September 17, 2026, the stock closed at ₹380.2, a slight increase from its previous close of ₹380.1 on the same day. There are no new filings or news developments reported as of September 18, 2026, indicating that the company's operational and strategic context remains unchanged from earlier periods. The technical indicators for daily and weekly trends are not available for comparison.

Syngene International Limited has been actively engaging with investors and analysts. The company participated in a physical one-on-one meeting with Healthcare Forum 2026, organized by Kotak Group, on September 17, 2026. Prior to this, Syngene attended a group meeting with Goldman Sachs at the Goldman Sachs Asia Leaders Conference 2026 in Hong Kong on August 31, 2026, and a virtual one-on-one meeting with Entrust Family Office on August 28, 2026. Earlier in August, the company participated in the Emkay Confluence 2026 conference in Mumbai on August 13-14, 2026. In all these instances, the company explicitly stated that no Unpublished Price Sensitive Information (UPSI) would be disclosed. On a separate note, on September 1, 2026, Syngene granted 14,26,061 Performance Share Units (PSUs) under its Long Term Incentive Performance Share Plan (PSP) 2023. These PSUs have an exercise price of ₹10 per unit and vest 100% after a three-year performance period, with options exercisable within five years of vesting. Additionally, on July 29, 2026, shareholders approved resolutions at the 33rd Annual General Meeting, including the adoption of financial statements for the year ended March 31, 2026, and a final dividend of ₹1.25 per equity share.

Syngene International's recent operating performance shows a mixed trajectory across the reported periods. Revenue from operations saw an increase from ₹917.10 crore in Q3 FY2025-26 to ₹1,036.50 crore in Q4 FY2025-26, before declining to ₹736 crore in Q1 FY2026-27. Expenses followed a similar pattern, rising from ₹833.50 crore in Q3 FY2025-26 to ₹856.70 crore in Q4 FY2025-26, and then decreasing to ₹767 crore in Q1 FY2026-27.

Profitability metrics indicate a significant shift. Profit Before Exceptional Items And Tax was ₹99 crore in Q3 FY2025-26, surged to ₹202 crore in Q4 FY2025-26, but turned negative at -₹5.70 crore in Q1 FY2026-27. This decline in operating profit, coupled with exceptional items before tax of -₹13.50 crore in Q1 FY2026-27, resulted in a Profit Before Tax of -₹19.20 crore for the latest quarter, compared to ₹196 crore in Q4 FY2025-26 and ₹28.40 crore in Q3 FY2025-26. Finance costs remained relatively stable, ranging from ₹9.60 crore to ₹12.10 crore across these periods.

Key monitoring areas for investors include the reversal of the recent decline in revenue and the return to profitability. Understanding the drivers behind the negative Profit Before Tax in Q1 FY2026-27, particularly the impact of exceptional items, will be crucial.

The company's monthly trend indicators show a bullish Supertrend signal as of the last observed date, suggesting potential upward momentum over a longer timeframe. However, daily and weekly trend indicators are currently bearish, with Exponential Moving Averages (EMAs) and Simple Moving Averages (SMAs) indicating downward price slopes. The stock is trading below its 20-day, 50-day, and 200-day SMAs and EMAs on a daily basis, and below its 20-day and 50-day SMAs and EMAs on a weekly basis. Several support levels are identified between ₹370.7 and ₹378.9, while resistance is noted around ₹383.6 and higher.

The company's stock is exhibiting a bearish trend on a daily and weekly basis, with key moving averages like the 20-day and 50-day Exponential Moving Averages (EMAs) and Simple Moving Averages (SMAs) trading above the current closing price of ₹380.2. The daily Supertrend indicator is also signaling a bearish direction. This technical setup suggests a prevailing downward momentum in the short to medium term. Furthermore, the stock has experienced significant drawdowns, with a current drawdown of -0.57 and a maximum drawdown of -0.57, indicating substantial price depreciation from its peak. The year-to-date return is -0.42, and the one-year return is also -0.42, highlighting a prolonged period of underperformance.